findinEsegui ricerca
Image

Newsletter 9, June 2015


Showcasing ENTENTE at TTS Europe

Editorial
Angela Baker
ENTENTE Coordinator
Director of European Affairs, Inserm Transfert

The ENTENTE Final Conference held jointly with the TTS Europe in Barcelona on 28-29 April attracted over 200 participants, drawn from TTOs, Venture capitalists, Industry and leading research organisations within and beyond Europe, to propose, discuss and debate how to facilitate technology transfer in the field of health.

This challenge is one that the ENTENTE community, with some 1000 members, has been addressing since 2012 providing technology transfer professionals and amateurs with the forum and tools needed to share and build on their expertise in technology transfer for the benefit of the wider community.

This Newsletter highlights some of this expertise notably three best practices as well as video interviews with the key panellists at the ENTENTE Final conference which we encourage you all to both enjoy and share further within your own networks.

Although the ENTENTE project is coming to a contractual close this Autumn we aim to keep this growing community alive. We look forward to telling you more about our future plans in our next and last issue due in August 2015.

 
INTERVIEWSINTERVIEWS
On April 28-29, , the TTS Europe 2015 was combined with the final conference of ENTENTE: two days of on-going interaction with top industry executives from biotech and pharma and leading VCs. The event offered unique opportunities for real understanding of challenges, obstacles and ways forward in health and tech transfer.

With the occasion of this event, the ENTENTE team interviewed VC and representatives from start-ups and SMEs.

Interview
Interview with Sir Greg Winter: Pioneer of Therapeutic Monocional Antibodies
Interview
How do investors evaluate start-ups
Interview
What does it mean to be an innovator in Academia
 
BEST PRACTICESBEST PRACTICES
InterviewRoyalty Monetization Primer, Current Trends, and Best Practices
In this presentation there is what royalty monetization is, how it works and why academic institutes should consider monetizing their future royalty income.
Best Practices for the Licensing of Genomic Inventions

A Grace Period For Patents
 
OUR NETWORKOUR NETWORK
InterviewBring your research results to the market

InterviewJoin knowledge transfer community

InterviewGet prepared for Horizon 2020
NEXT EVENTSNEXT EVENTS
25-26 June 2015 - Paris (France)
Hello tomorrow conference

1st July 2015 - Brussels (Belgium)
Health-2-Market Final Conference

9-10 September 2015 - Stockholm (Sweden)
Nordic Life Science Days 2015
See more events
 
FOLLOW US
twitterFollow us @EntenteEU and Stay tuned with the latest news from the #TechTransfer in #Health And share your thoughts with us!

 

 

Do you want to receive the next Entente Newsletters?join our community
This project has received funding from the European Union’s Seventh Programme for 
research, technological development and demonstration under grant agreement No 305128
 
  ENTENTE is supported by the European Commission and coordinated by Inserm-Transfert SA